RxDoctor Payments Data

Suzann Smith

Family · Manchester, KYNPI 1811220171

Payments from drug & device makers

$3,542in general payments, 2019–2025

Across 207 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$887
  • Otsuka America Pharmaceutical, Inc.$333
  • Novo Nordisk$283
  • Merck$237
  • Johnson & Johnson$222
  • Axsome Therapeutics, Inc.$196
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,542100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,542 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole51$73,132
Vilazodone Hcl24$2,846
Aripiprazole37$830
Buspirone Hcl42$290
Duloxetine Hcl30$236
Fluoxetine Hcl70$229
Mirtazapine48$229
Bupropion XlBupropion Hcl63$207
Hydroxyzine Pamoate40$205
Lamotrigine68$204
Amitriptyline Hcl48$201
Prazosin Hcl20$131
Hydroxyzine Hcl18$121
Quetiapine Fumarate33$101
Gabapentin13$93

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$333$73,13251 claims
Lilly USA, LLCOlanzapine$180$8713 claims
Almatica Pharma LLCSertraline Hcl$14$7833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Manchester

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →